Claimed to be a first-of-its-kind digital laparoscopic platform, Senhance Surgical System has been installed in the hospital’s General Surgery Department.
Powered by the company’s Intelligent Surgical Unit (ISU), the technology platform uses augmented intelligence to support performance and achieve better patient outcomes through machine learning.
The ISU provides machine vision-driven control of the camera by reacting to commands and identifying some objects and locations in the surgical field.
Furthermore, surgeons can change the visualised field by moving their instruments.
The expanded ISU’s advanced features include digital tagging, 3D measurement, image enhancement, and improved camera control supported by real-time data obtained during surgical procedures from anatomical structures.
Asensus Surgical president and CEO Anthony Fernando said: “Goettingen-Weende has a significant laparoscopic programme within their general surgery department.
“We are excited to bring the benefits of Senhance’s digital laparoscopy and Performance-Guided Surgery to these experienced surgeons.
“We look forward to collaborating with the Goettingen-Weende team to work towards increasing utilisation of their Senhance system to help provide enhanced care to their patients.”
The company stated that the Senhance Surgical System offers surgical assurance through 3D visualisation, eye-tracking camera control and haptic feedback.
It is also claimed to be the first platform to provide 3mm instruments, the world’s smallest instruments available on a robotic surgical platform.
Furthermore, the open-platform architecture of the system enables seamless integration of surgeon preference tools, such as the 3DHD visualisation system.
Last September, Asensus Surgical’s ISU received 510(k) clearance from the US Food and Drug Administration (FDA).